FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Powerful Democratic Donors Terrified About 2028 Due to ‘Floundering’ DNC: Report

NY Sheriff Defies Kathy Hochul’s New Law That Seeks to Block Law Enforcement from Working with ICE

Pro-Trump influencer Laura Loomer shifts toward Ukraine support

Trump questions Thune’s leadership as SAVE America Act stalls

Op-Ed: The First Amendment Isn’t Optional

Army veteran raves over Trump’s plan to ditch illegal alien truck drivers and hire vets

The generational divide over affordability in the Trump economy is all about housing

How One Congressional Resolution Could Save the Midterms: The GOP’s Hindu Vote Gamble

Troy Jackson swapped out Senate campaign official also behind the super PAC backing Abdul el Sayed

Mystery stranger vanishes after family says frantic warning saved their lives during devastating house fire

WNBA Headache Gets Bigger: More Sophie Cunningham Rallies Scheduled

Nancy Guthrie update: DNA couldn’t be profiled from crime scene hair sample, sheriff says

GOP gubernatorial candidate fighting to flip blue state unveils healthcare plan to lower costs, expand access

WATCH: GOP holdout rejects Trump threat as AG nominee standoff explodes

Influencer accused of targeting wealthy dating app matches back behind bars

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”